Skip to main content
Premium Trial:

Request an Annual Quote

MWG Biotech, Qiagen, Epoch Biosciences

Premium

MWG Biotech has launched its MWG Human 40K Array, which comprises 40,000 human genes on two microarray slides. The 40K A Array has 20,000 genes with “full functional characterization and content referencing,” and the 40K B Array has whose 20,000 genes that are referenced against “several” NCBI databases.

MWG said 21 Gene Ontology-based functional groups, which are located in 384-well plates, were created for the Human 40K Array, whose groups reside in 384-well plates. MWG used its Oligos4Arrays software to design the gene-specific 50-mer oligonucleotides used on the Human 40K Array.


Qiagen has launched Epoch BiosciencesQuantiTect custom gene-expression assays and probe and primer sets for quantitative real-time PCR based on Epoch’s MGB Eclipse technology.

The assays were developed by integrating Epoch’s software and Qiagen’s web-based ordering. In November 2002, the companies penned a marketing agreement that gave Qiagen co-exclusive worldwide sales and marketing rights to products incorporating Epoch’s MGB Eclipse probe systems. Terms of that deal called for Qiagen to receive a license to the component technologies, and for Epoch to receive access fees and royalties.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.